Literature DB >> 6929277

The cellular basis of self renewal in culture by human acute myeloblastic leukemia blast cell progenitors.

L J Chang, J E Till, E A McCulloch.   

Abstract

Blast cells from patients with Acute Myeloblastic Leukemia (AML) were separated according to cell size using velocity sedimentation under unit gravity. Fractions obtained in this way were plated in methyl cellulose with a growth stimulator present in media conditioned by leukocytes in the presence of phytohemagglutinin (PHA-LCM). Colonies of blast cells form under these conditions. Pooled cell suspensions from such colonies were plated in microwells; the plating efficiency of such suspensions is a measure of blast progenitor self-renewal occurring in the original blast colonies. Self-renewal assays on each fraction indicated that self renewal among blast progenitors is heterogeneously distributed with subpopulations differing in renewal capacities. The results are consistent with the view that blast cell subpopulations in AML undergo a series of transitions associated with decreasing self renewal capacity, analogous to that observed in normal hemopoiesis, where proliferative capacity decreases with increasing differentiation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6929277     DOI: 10.1002/jcp.1041020213

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Disconnection of genes coding for self-renewal and differentiation: a possible mechanism of diversity in acute myeloid leukemias.

Authors:  H von Melchner; K Höffken
Journal:  Blut       Date:  1985-05

2.  A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.

Authors:  Suraj Bansal; Liqing Jin; Andy G X Zeng; Amanda Mitchell; Weihsu Claire Chen; Hussein A Abbas; Michelle Chan-Seng-Yue; Veronique Voisin; Peter van Galen; Anne Tierens; Meyling Cheok; Claude Preudhomme; Hervé Dombret; Naval Daver; P Andrew Futreal; Mark D Minden; James A Kennedy; Jean C Y Wang; John E Dick
Journal:  Nat Med       Date:  2022-05-26       Impact factor: 87.241

3.  ASTA Z 7557 (INN mafosfamide) for the in vitro treatment of human leukemic bone marrows.

Authors:  L Douay; N C Gorin; J P Laporte; M Lopez; A Najman; G Duhamel
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

4.  Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases.

Authors:  L Coulombel; C Eaves; D Kalousek; C Gupta; A Eaves
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

5.  Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival.

Authors:  F L Meyskens; S P Thomson; J Buckmeier
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.